The general mood among these heavyweight investors is divided, with 33% leaning bullish and 66% bearish. Among these notable options, 6 are puts, totaling $210,150, and 3 are calls, amounting to ...

Ubrelvy and Nurtec are prescription medications taken to treat migraines. Though they share similarities, Ubrelvy is for acute treatment, while Nurtec can be taken for immediate symptom relief.

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

In a clinical guideline issued by the American College of Physicians and published online Feb. 4 in the Annals of Inte ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Many people use the terms ‘migraine’ and ‘headache’ interchangeably. This leads many people to believe that migraines are not ...

That's concerning, because "without a proper diagnosis, medications that can help reduce migraine may be delayed," noted study author Dr. Marissa Maliakal Anto of the University of Pennsylvania in ...

A new article, published in the International Journal of Environmental Research and Public Health, unveils a software application that transforms patients' homes into therapeutic environments for ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...

Migraine costs the U.S. economy more than $23 billion each year. The Migraine Research Program at Mayo Clinic focuses on better understanding and treatment of this common, functionally complex and ...